Search Clinical Trials
589,087 trials
ID
Status
Phase
Title
Sponsor
NCT07644247
STudy of Aspirin Removal in Patients Supported by the Fully Magnetically Levitated CH-VAD PumpBeijing Anzhen HospitalNot Yet RecruitingPhase 4
NCT07644247Not Yet Recruiting
Phase 4
STudy of Aspirin Removal in Patients Supported by the Fully Magnetically Levitat...Beijing Anzhen Hospital
NCT07645313
Accuracy and Safety of Anytime 5Pro and Anytime 4Pro CGM Systems in Adults With DiabetesJiangsu Yuwell POCTech Biotechnology Co., Ltd..Not Yet RecruitingNot Applicable
NCT07645313Not Yet Recruiting
Not Applicable
Accuracy and Safety of Anytime 5Pro and Anytime 4Pro CGM Systems in Adults With...Jiangsu Yuwell POCTech Bi...
NCT07646340
Long-term Pelvic Floor and Sexual Health After Obstetric Anal Sphincter Injury in FinlandTampere University HospitalEnrolling By Invitation
NCT07646340Enrolling By Invitation
—
Long-term Pelvic Floor and Sexual Health After Obstetric Anal Sphincter Injury i...Tampere University Hospit...
NCT07645417
Maxillary Canine Retraction Using Stainless Steel and Titanium-molybdenum Alloy Wires in TAD-supported Segmental MechanicsTanzila RafiqueEnrolling By InvitationNot Applicable
NCT07645417Enrolling By Invitation
Not Applicable
Maxillary Canine Retraction Using Stainless Steel and Titanium-molybdenum Alloy...Tanzila Rafique
NCT07644702
WE-CARE Community Health Forums to Increase Breast Cancer Screening and Clinical Trial Participation for Rural and Low Income WomenMayo ClinicRecruitingNot Applicable
NCT07644702Recruiting
Not Applicable
WE-CARE Community Health Forums to Increase Breast Cancer Screening and Clinical...Mayo Clinic
NCT07645976
Home Environmental Risks and Caregiver AwarenessMarmara University Pendik Training and Research HospitalCompleted
NCT07646418
Combined Effects of LIRT-BFR Therapy in Post- Stroke PatientsRiphah International UniversityRecruitingNot Applicable
NCT07646418Recruiting
Not Applicable
Combined Effects of LIRT-BFR Therapy in Post- Stroke PatientsRiphah International Univ...
NCT07645586
A Phase 3 Trial of Lesion Network Mapping-Guided cTBS for Motor Recovery After Acute Ischemic StrokeBeijing Tiantan HospitalNot Yet RecruitingPhase 3
NCT07645586Not Yet Recruiting
Phase 3
A Phase 3 Trial of Lesion Network Mapping-Guided cTBS for Motor Recovery After A...Beijing Tiantan Hospital
NCT07644936
Molecular Characterization of Autoimmune Hepatitis: A Lipidomic ApproachAzienda Ospedaliera Specializzata in Gastroenterologia Saverio de BellisNot Yet Recruiting
NCT07644936Not Yet Recruiting
—
Molecular Characterization of Autoimmune Hepatitis: A Lipidomic ApproachAzienda Ospedaliera Speci...
NCT07645183
Advanced Technology for Myopia Control in Children and Young AdultsUniversity of FaisalabadCompletedNot Applicable
NCT07645183Completed
Not Applicable
Advanced Technology for Myopia Control in Children and Young AdultsUniversity of Faisalabad
NCT07645235
A Study to Evaluate Gepotidacin Exposure in Breast Milk of Healthy Lactating WomenBiomedical Advanced Research and Development AuthorityNot Yet RecruitingPhase 1
NCT07645235Not Yet Recruiting
Phase 1
A Study to Evaluate Gepotidacin Exposure in Breast Milk of Healthy Lactating Wom...Biomedical Advanced Resea...
NCT07645196
Effects of Physiotherapy on Ultrasound and Clinical Parameters in Women With DysmenorrheaVrije Universiteit BrusselNot Yet RecruitingNot Applicable
NCT07645196Not Yet Recruiting
Not Applicable
Effects of Physiotherapy on Ultrasound and Clinical Parameters in Women With Dys...Vrije Universiteit Brusse...
NCT07645014
Comparative Effects of Neurodynamic Stretch and Myofascial Pain Release in Polycystic Ovarian Syndrome.Riphah International UniversityRecruitingNot Applicable
NCT07645014Recruiting
Not Applicable
Comparative Effects of Neurodynamic Stretch and Myofascial Pain Release in Polyc...Riphah International Univ...
NCT07645248
A Study to Compare Safety of 4 Weeks Exposure to Propellants Hydrofluoroalkane 1,1-difluoroethane (HFA-152a) and HFA-1,1,1,2-tetrafluoroethane (134a)GlaxoSmithKlineNot Yet RecruitingPhase 3
NCT07645248Not Yet Recruiting
Phase 3
A Study to Compare Safety of 4 Weeks Exposure to Propellants Hydrofluoroalkane 1...GlaxoSmithKline
NCT07646431
Comparative Effects Of Clamshell And Short Arc Quadriceps Exercises In Patellofemoral PainGreen International UniversityCompletedNot Applicable
NCT07646431Completed
Not Applicable
Comparative Effects Of Clamshell And Short Arc Quadriceps Exercises In Patellofe...Green International Unive...
NCT07644104
Efficacy and Safety of the Visual Bronchial Blocker for Lung Isolation SurgeryZhejiang UniversityNot Yet RecruitingNot Applicable
NCT07644104Not Yet Recruiting
Not Applicable
Efficacy and Safety of the Visual Bronchial Blocker for Lung Isolation SurgeryZhejiang University
NCT07644897
Thymosin Alpha 1 Combined With Anti-PD-1 Monoclonal Antibody in Elderly Patients With Advanced MelanomaSun Yat-sen UniversityRecruitingPhase 2
NCT07644897Recruiting
Phase 2
Thymosin Alpha 1 Combined With Anti-PD-1 Monoclonal Antibody in Elderly Patients...Sun Yat-sen University
NCT07645404
The Effect of Mental Fatigue on Upper Extremity Functional PerformanceIzmir Bakircay UniversityNot Yet RecruitingNot Applicable
NCT07645404Not Yet Recruiting
Not Applicable
The Effect of Mental Fatigue on Upper Extremity Functional PerformanceIzmir Bakircay University
NCT07644442
Study on [14C]HMPL-453(FGFR Inhibitor) in Healthy Chinese Adult Male SubjectsHutchmedCompletedPhase 1
NCT07644442Completed
Phase 1
Study on [14C]HMPL-453(FGFR Inhibitor) in Healthy Chinese Adult Male SubjectsHutchmed
NCT07645534
Safety and Pharmacokinetics of Ingavirin Forte, Capsules, 90 mg + 20 mg (Valenta Pharm JSC, Russia) Compared With Ingavirin, Capsules, 90 mg, Under Fasting and Fed Conditions.Valenta Pharm JSCRecruitingPhase 1
NCT07645534Recruiting
Phase 1
Safety and Pharmacokinetics of Ingavirin Forte, Capsules, 90 mg + 20 mg (Valenta...Valenta Pharm JSC
Result Breakdown
Not yet recruiting9 (45%)
Recruiting5 (25%)
Completed4 (20%)
Enrolling by invitation2 (10%)
not_applicable10 (50%)
Not Specified3 (15%)
Phase 13 (15%)
Phase 32 (10%)
Phase 41 (5%)
Phase 21 (5%)